Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-79457 |
Brand: | MCE |
CAS: | 867-44-7 |
MDL | MFCD00013055 |
---|---|
Molecular Weight | 139.18 |
Molecular Formula | C2H6N2S.1/2H2O4S |
SMILES | NC(SC)=N.O=S(O)(O)=O.[1/2] |
S-Methylisothiourea sulfate is a potent, selective and competitive inhibitor of inducible nitric oxide synthase (iNOS) . S-Methylisothiourea sulfate exerts beneficial effects in rodent models of septic shock [1] .
iNOS [1]
S-Methylisothiourea sulfate is a competitive inhibitor of iNOS activity at the L-arginine site
[1]
.
S-Methylisothiourea sulfate prevents the NO-mediated cytotoxic effect of LPS in cultured macrophages
[1]
.
S-Methylisothiourea sulfate (100 nM-100 μM) exhibits inhibitory effects on LPS (ug/mL)-induced nitrite production in J774.2 macrophages and rat aortic vascular smooth muscle cells
[1]
.
S-Methylisothiourea sulfate (up to 1 mM) does not inhibit the activity of xanthine oxidase, diaphorase, lactate dehydrogenase, monoamine oxidase, catalase, cytochrome P450, or superoxide dismutase
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
S-Methylisothiourea sulfate (0.01-3 mg/kg; i.v.) dose-dependently reverses the hypotension and the vascular hyporeactivity to vasoconstrictor agents caused by endotoxin LPS in anesthetized rats
[1]
.
S-Methylisothiourea sulfate (5 mg/kg; i.p.; given 2 hr after LPS; 10 mg/kg; i.p.) attenuates the rises in plasma alanine and aspartate aminotransferases, bilirubin, and creatinine and also prevents hypocalcaemia when measured 6 hr after administration of LPS
[1]
.
S-Methylisothiourea sulfate (1 mg/kg; i.p.) improves 24-hr survival of mice treated with a high dose of LPS (60 mg/kg; i.p.)
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Male Wistar rats (260-320 g) [1] |
Dosage: | 0.01 mg/kg, 0.1 mg/kg, 1 mg/kg, 3 mg/kg |
Administration: | Intravenous injection |
Result: | Caused a prompt restoration of the blood pressure to pre-LPS levels at 3 mg/kg dose in LPS (10 mg/kg, i.v.)-treated rats; Inhibited iNOS activity measured in homogenates of lung. |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
H 2 O : 65 mg/mL ( 467.02 mM ; Need ultrasonic)
DMSO : < 1 mg/mL (insoluble or slightly soluble)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 7.1849 mL | 35.9247 mL | 71.8494 mL |
5 mM | 1.4370 mL | 7.1849 mL | 14.3699 mL |
10 mM | 0.7185 mL | 3.5925 mL | 7.1849 mL |
Add each solvent one by one: PBS
Solubility: 50 mg/mL (359.25 mM); Clear solution; Need ultrasonic
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.